NEW YORK (Reuters) - Lawmakers will hold a hearing on Johnson & Johnson's recall of Children's Tylenol and other over-the-counter medicines later this month, and have asked the company's CEO to testify.
The House Committee on Oversight and Government Reform will hold a hearing on May 27, and has asked J&J Chief Executive William Weldon to testify, according to the panel's website.
The company recently recalled 40 widely used children's pain and allergy medications, saying some may have a higher concentration of their active ingredients, while others may be contaminated. J&J has had four recalls in the past year of over-the-counter medicines.
Food and Drug Administration inspectors have said they found thick dust, grime and contaminated ingredients at the J&J plant that produces Children's Tylenol and dozens of other products.
J&J has called the manufacturing problems unacceptable and vowed to fix them. The company has suspended production at the Pennsylvania plant where the recalled children's products are made.
(Reporting by Ritsuko Ando and Lewis Krauskopf; Editing by Richard Chang)